Virtual training takes on sight-threatening condition caused by diabetes
September 23, 2021
Orbis, with support from FedEx, is offering training that will develop ophthalmologists’ skills to treat diabetic retinopathy in China.
© 2021 MJH Life Sciences™ and Ophthalmology Times. All rights reserved.
All News
ASRS launches See for a Lifetime See a Retina Specialist education initiative
September 23, 2021
American Society of Retinal Specialists program to drive awareness and action around retinal diseases that put millions at risk for blindness.
Horizon Therapeutics releases Phase 2/3 results for inebilizumab-cdon
September 23, 2021
The company announced that inebilizumab-cdon produces rapid and sustained B-cell depletion in African Americans with neuromyelitis optica spectrum disorder.
Study: Heru’s automated VF testing platform shows strong link to Humphrey Field Analyzer
September 22, 2021
A recent report by Heru Inc. has found that visual field (VF) results from re:Vive, its wearable testing platform, have a strong association to the ZEISS Humphrey Field Analyzer (HFA).
COVID-19 vaccination inequities in Massachusetts
September 21, 2021
Massachusetts researchers are reporting structural disparities in vaccine distribution in the state.
Bejeweled 17th century eyeglasses on block at Sotheby’s
September 21, 2021
The eyeglasses were reportedly designed to help the wearer reach enlightenment and drive away evil, according to Sotheby’s London, which will host the auction next month.
Ophthalmologist Patricia Bath, MD, selected for posthumous induction into National Inventors Hall of Fame
September 21, 2021
Bath, who invented the Laserphaco Probe for treating cataracts, is the first African-American woman inducted into the National Inventors Hall of Fame.
Glaukos unveils licensing agreement for compounds that target Demodex mites
September 20, 2021
Glaukos has entered into a licensing agreement with Attillaps Holdings Inc., giving it an exclusive license to research, develop, manufacture and commercialize Attillaps’ proprietary library of investigational pharmaceutical compounds that target the eradication of Demodex mites.
Ranibizumab-nuna biosimilar receives FDA approval
September 20, 2021
According to Samsung Bioepis and Biogen, ranibizumab-nuna becomes the first ophthalmology biosimilar to gain FDA approval in the United States.
COVID-19 vaccination during pregnancy: No link to spontaneous abortion
September 19, 2021
Researchers conducting a case-control surveillance of COVID-19 vaccination during pregnancy found that spontaneous abortions did not increase as a result of vaccinations.